NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

Last Close
Apr 25 04:00PM ET
20.62
Dollar change
-0.26
Percentage change
-1.25
%
CategoryUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsU.S. Return% 1Y-0.09% Shs Outstand Perf Week4.04%
SponsorInvesco ETF Type Tagsequity Return% 3Y0.50% Total Holdings264 Perf Month-4.85%
Fund Family Bond Type Tagsbiotechnology Return% 5Y- AUM37.31M Perf Quarter-7.87%
IndexNASDAQ Biotechnology Index Average Maturity Tags- Return% 10Y NAV% Perf Half Y-13.29%
Index Weighting Commodity Type Tags- Return% SI NAV/sh Perf Year-0.96%
Active/Passive Quant Type Tags- Flows% 1M-2.61% 52W Range17.84 - 24.84 Perf YTD-4.18%
Dividend TTM0.24 (1.17%) ESG Type Tags- Flows% 3M2.74% 52W High-16.99% Beta0.69
Dividend Ex-DateMar 24, 2025 Dividend Type Sector/Theme Flows% YTD2.74% 52W Low15.58% ATR (14)0.56
Expense0.19% Structure Type Region Flows% 1Y RSI (14)50.56 Volatility1.56% 2.85%
Option/ShortYes / Yes Growth/Value Dev/Emerg Flows% 3Y Rel Volume0.48 Prev Close20.88
Inverse/Leveraged Market Cap Currency Flows% 5Y Avg Volume15.48K Price20.62
SMA202.69% SMA50-3.93% SMA200-9.58% Trades Volume7,492 Change-1.25%
Invesco Nasdaq Biotechnology ETF seeks to track the investment results (before fees and expenses) of the Nasdaq Biotechnology Index . The fund generally will invest at least 90% of its total assets in the securities that comprise the index. Strictly in accordance with its guidelines and mandated procedures, Nasdaq compiles the underlying index, which is a modified market capitalization weighted index that is designed to measure the performance of securities listed on the Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical companies. The index may include securities of large-, mid- and small-capitalization companies. The fund is non-diversified.